ADAM17 and lung adenocarcinoma: Similarly, Cai et al. claimed that miR-326 repressed epithelial-to-mesenchymal transition of lung adenocarcinoma cells by targeting a disintegrin and metalloprotease 17 (ADAM17) [43].